Ana Vitlic, Postdoctoral Research Associate at The University of Manchester, shared on LinkedIn:
“Delighted that our application to the CRUK Horizon Validation Fund was successful!
This will help us take our work on immune remodelling in AML and ageing to the next stage. We’re really proud to have generated the preliminary data in such a short time, supported by our BCUK Pilot Grant.
Huge thanks to my PI for believing in this project and supporting me along the way, and to Nathalie for helping make it happen. Excited for what’s next!”
You can also read:
Daunorubicin: How a Bacterial Natural Product Became Part of AML’s Most Enduring Regimen
